Morphochemical Changes in the Human Striatum in Aging
- 8 Downloads
Age-dependent neurodegenerative diseases, including Parkinson’s disease, are characterized by a group of pathomorphological signs, such as neuronal death in certain brain structures, gliosis, and iron accumulation. However, literature data confirm that these signs can also be observed in normal (physiological) aging. The aim of the study is to evaluate qualitative and quantitative morphochemical changes in neurons and neuroglia in the human striatum in physiological aging, as well as changes in the localization of iron(II) compounds. It is found that neuronal cell bodies become significantly smaller in size at older ages, as compared with mature years, although the density of their distribution does not differ; the distribution density of total neuroglia and astrocytes, however, becomes higher at older ages. In addition, accumulations of iron(II) compounds are diagnosed along the vascular walls and inside the cytoplasm of neurons and glial cells. The indicators of physiological aging obtained in this research may serve as a basis for comparative studies of neurodegenerative processes in normal and pathological aging and for the pathomorphological diagnosis of age-associated neurodegenerative diseases, including Parkinson’s disease.
Keywords:physiological aging human brain striatum neurons astrocytes iron depositions
COMPLIANCE WITH ETHICAL STANDARDS
Conflict of interests. The authors declare that they have no conflict of interest.
Statement on the welfare of animals. All applicable international, national, and/or institutional guidelines for the care and use of animals were followed.
- 1.Agapov, P.A., Bogolepova, I.N., and Malofeeva, L.I., Change of the size of neurons and density of neurons and glia of the 7 area of the women’s brain crease in the aging processes, Mezhdunar. Zh. Prikl. Fundam. Issled., 2017, no. 5-2, pp. 274–280.Google Scholar
- 2.Pal’tsyn, A.A. and Komissarova, S.V., Age-related changes of the brain, Patol. Fiziol. Eksp. Ter., 2015, vol. 59, no. 4, pp. 108–116.Google Scholar
- 3.Błaszczyk, J.W., Nigrostriatal interaction in the aging brain: new therapeutic target for Parkinson’s disease, Acta Neurobiol. Exp., 2017, vol. 77, no. 1, pp. 106–112.Google Scholar
- 4.Brasnjevic, I., Hof, P.R., Steinbusch, H.W.M., and Schmitz, C., Accumulation of nuclear DNA damage or neuron loss: Molecular basis for a new approach to understanding selective neuronal vulnerability in neurodegenerative diseases, DNA Repair, 2008, vol. 7, no. 7, pp. 1087–1097.CrossRefGoogle Scholar
- 17.Lynch, A.M., Murphy, K.J., Deighan, B.F., et al., The impact of glial activation in the aging brain, Aging Dis., 2010, vol. 1, no. 3, pp. 262–278.Google Scholar
- 18.Mann, D.M.A., Sense and Senility: The Neuropathology of the Aged Human Brain, Ch. 2 Pathological Changes in the Elderly Human Brain, Neuroscience Intelligence Unit Series, Boston: Springer-Verlag, 1997.Google Scholar
- 19.Moreno-García, A., Kun, A., Calero, O., et al., An overview of the role of lipofuscin in age-related neurodegeneration, Front. Neurosci., 2018, vol. 12, p. 464.Google Scholar